Redox Partners: Function Modulators of Bacterial P450 Enzymes

Trends in Microbiology

Volumn 28, Issue 6, 2020, Pages 445-454

  Li, Shengying ^a,b   Du, Lei ^a,c   Bernhardt, Rita ^d  

^a SHANDONG UNIVERSITY   (China)

^b QINGDAO NATIONAL LABORATORY FOR MARINE SCIENCE AND TECHNOLOGY   (China)

^c QINGDAO INSTITUTE OF BIOENERGY AND BIOPROCESS TECHNOLOGY   (China)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

cytochrome P450 enzymes; electron transfer; ferredoxin; ferredoxin reductase; protein protein interactions; redox partners

Indexed keywords

CYTOCHROME P450 MONOOXYGENASE; CYTOCHROME P450 REDUCTASE; OXYGEN; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE; BACTERIAL PROTEIN; CYTOCHROME P450; FERREDOXIN; MITOCHONDRIAL PROTEIN; OXIDOREDUCTASE;

BACTERIAL METABOLISM; BINDING AFFINITY; CATALYSIS; CRYOELECTRON MICROSCOPY; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME SUBSTRATE COMPLEX; NONHUMAN; OXIDATION REDUCTION STATE; OXYGENATION; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REVIEW; X RAY CRYSTALLOGRAPHY; BACTERIUM; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN DOMAIN;

BACTERIA; BACTERIAL PROTEINS; CYTOCHROME P-450 ENZYME SYSTEM; ELECTRON TRANSPORT; FERREDOXINS; MITOCHONDRIAL PROTEINS; OXIDATION-REDUCTION; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 85081723275     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2020.02.012     Document Type: Review

References (50)

1. Nelson, D.R., et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6 (1996), 1–42.
2. Sezutsu, H., et al. Origins of P450 diversity. Phil. Trans. R. Soc. B., 368, 2013, 20120428.
3. Nebert, D.W., et al. Evolution of the cytochrome P450 genes. Xenobiotica 19 (1989), 1149–1160.
4. Guengerich, F.P., Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. 14 (2001), 611–650.
5. Zhang, X., Li, S., Expansion of chemical space for natural products by uncommon P450 reactions. Nat. Prod. Rep. 34 (2017), 1061–1089.
6. Urlacher, V.B., Girhard, M., Cytochrome P450 monooxygenases in biotechnology and synthetic biology. Trends Biotechnol. 37 (2019), 882–897.
7. Werck-Reichhart, D., Feyereisen, R., Cytochromes P450: a success story. Genome Biol., 1, 2000, reviews3003.
8. Sono, M., et al. Heme-containing oxygenases. Chem. Rev. 96 (1996), 2841–2887.
9. Denisov, I.G., et al. Structure and chemistry of cytochrome P450. Chem. Rev. 105 (2005), 2253–2277.
10. Guengerich, F.P., Rate-limiting steps in cytochrome P450 catalysis. Biol. Chem. 383 (2002), 1553–1564.
11. Hannemann, F., et al. Cytochrome P450 systems – biological variations of electron transport chains. Biochim. Biophys. Acta 1770 (2007), 330–344.
12. Lewis, D.F.V., Hlavica, P., Interactions between redox partners in various cytochrome P450 systems: functional and structural aspects. Biochim. Biophys. Acta 1460 (2000), 353–374.
13. Riddick, D.S., et al. NADPH-cytochrome P450 oxidoreductase: Roles in physiology, pharmacology, and toxicology. Drug Metab. Disposition 41 (2013), 12–23.
14. Ciaramella, A., et al. Catalytically self-sufficient cytochromes P450 for green production of fine chemicals. Rend. Fis. Acc. Lincei 28 (2017), 169–181.
15. Bernhardt, R., The role of adrenodoxin in adrenal steroidogenesis. Curr. Opin. Endocrinol. Diabetes 7 (2000), 109–115.
16. Zhang, W., et al. New reactions and products resulting from alternative interactions between the P450 enzyme and redox partners. J. Am. Chem. Soc. 136 (2014), 3640–3646.
17. Ewen, K.M., et al. Adrenodoxin: the archetype of vertebrate-type [2Fe-2S] cluster ferredoxins. Biochim. Biophys. Acta 1814 (2011), 111–125.
18. Keizers, P.H.J., et al. A solution model of the complex formed by adrenodoxin and adrenodoxin reductase determined by paramagnetic NMR spectroscopy. Biochemistry 49 (2010), 6846–6855.
19. Strushkevich, N., et al. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10139–10143.
20. Tripathi, S., et al. Structural basis for effector control and redox partner recognition in cytochrome P450. Science 340 (2013), 1227–1230.
21. Zhang, W., et al. Solution NMR structure of putidaredoxin-cytochrome P450cam complex via a combined residual dipolar coupling-spin labeling approach suggests a role for trp106 of putidaredoxin in complex formation. J. Mol. Biol. 384 (2008), 349–363.
22. Hiruma, Y., et al. The structure of the cytochrome P450cam-putidaredoxin complex determined by paramagnetic NMR spectroscopy and crystallography. J. Mol. Biol. 425 (2013), 4353–4365.
23. Andralojc, W., et al. Identification of productive and futile encounters in an electron transfer protein complex. Proc. Natl. Acad. Sci. U. S. A. 114 (2017), E1840–E1847.
24. Chun, Y.-J., et al. Electron transport pathway for a Streptomyces cytochrome P450 – cytochrome P450 105D5-catalyzed fatty acid hydroxylation in Streptomyces coelicolor A3(2). J. Biol. Chem. 282 (2007), 17486–17500.
25. Ewen, K.M., et al. Genome mining in Sorangium cellulosum So ce56: identification and characterization of the homologous electron transfer proteins of a myxobacterial cytochrome P450. J. Biol. Chem. 284 (2009), 28590–28598.
26. Zhang, W., et al. Mechanistic insights into interactions between bacterial class I P450 enzymes and redox partners. ACS Catal. 8 (2018), 9992–10003.
27. Kuznetsov, V.Y., et al. The putidaredoxin reductase-putidaredoxin electron transfer complex – theoretical and experimental studies. J. Biol. Chem. 280 (2005), 16135–16142.
28. Bernhardt, R., Urlacher, V.B., Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations. Appl. Microbiol. Biotechnol. 98 (2014), 6185–6203.
29. Ma, L., et al. Reconstitution of the in vitro activity of the cyclosporine-specific P450 hydroxylase from Sebekia benihana and development of a heterologous whole-cell biotransformation system. Appl. Environ. Microbiol. 81 (2015), 6268–6275.
30. Cao, P.R., Bernhardt, R., Modulation of aldosterone biosynthesis by adrenodoxin mutants with different electron transport efficiencies. Eur. J. Biochem. 265 (1999), 152–159.
31. Katagiri, M., et al. The role of cytochrome b5 in the biosynthesis of androgens by human P450c17. Arch. Biochem. Biophys. 317 (1995), 343–347.
32. Fluck, C.E., et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley–Bixler syndrome. Nat. Genet. 36 (2004), 228–230.
33. Ewen, K.M., et al. Functional characterization of fdx1: Evidence for an evolutionary relationship between P450-type and ISC-type ferredoxins. J. Mol. Biol. 413 (2011), 940–951.
34. Anzai, Y., et al. Functional analysis of MycCI and MycG, cytochrome P450 enzymes involved in biosynthesis of mycinamicin macrolide antibiotics. Chem. Biol. 15 (2008), 950–959.
35. Sagadin, T., et al. Binding modes of CYP106A2 redox partners determine differences in progesterone hydroxylation product patterns. Commun. Biol., 1, 2018, 99.
36. Kim, J.D., et al. Energetic selection of topology in ferredoxins. PLoS Comp. Biol., 8, 2012, e1002463.
37. Poudel, S., et al. Electron transfer to nitrogenase in different genomic and metabolic backgrounds. J. Bacteriol., 200, 2018, e00757-00717.
38. Khatri, Y., et al. The CYPome of Sorangium cellulosum So ce56 and identification of CYP109D1 as a new fatty acid hydroxylase. Chem. Biol. 17 (2010), 1295–1305.
39. Kern, F., et al. Highly efficient CYP167A1 (EpoK) dependent epothilone B formation and production of 7-ketone epothilone D as a new epothilone derivative. Sci. Rep., 5, 2015, 14881.
40. Qi, F., et al. Deciphering the late steps of rifamycin biosynthesis. Nat. Commun., 9, 2018, 2342.
41. Li, Q., et al. AbmV catalyzes tandem ether installation and hydroxylation during neoabyssomicin/abyssomicin biosynthesis. Org. Lett. 20 (2018), 4854–4857.
42. Du, L., et al. Selective oxidation of aliphatic C–H bonds in alkylphenols by a chemomimetic biocatalytic system. Proc. Natl. Acad. Sci. U. S. A. 114 (2017), E5129–E5137.
43. Yu, Z., et al. Characterizing two cytochrome P450s in tiacumicin biosynthesis reveals reaction timing for tailoring modifications. Org. Lett. 21 (2019), 7679–7683.
44. Li, S., et al. Engineering and analysis of a self-sufficient biosynthetic cytochrome P450 PikC fused to the RhFRED reductase domain. J. Am. Chem. Soc. 129 (2007), 12940–12941.
45. Khatri, Y., et al. Investigating the effect of available redox protein ratios for the conversion of a steroid by a myxobacterial CYP260A1. FEBS Lett. 591 (2017), 1126–1140.
46. Straathof, A.J.J., et al. The production of fine chemicals by biotransformations. Curr. Opin. Biotechnol. 13 (2002), 548–556.
47. Nguyen, K.T., et al. Changing the regioselectivity of a P450 from C15 to C11 hydroxylation of progesterone. ChemBioChem 13 (2012), 1161–1166.
48. Sagadin, T., et al. Novel approach to improve progesterone hydroxylation selectivity by CYP106A2 via rational design of adrenodoxin binding. FEBS J. 286 (2019), 1240–1249.
49. Cammack, R., Iron–sulfur clusters in enzymes: themes and variations. Adv. Inorg. Chem. 38 (1992), 281–322.
50. Aliverti, A., et al. Structural and functional diversity of ferredoxin-NADP(+) reductases. Arch. Biochem. Biophys. 474 (2008), 283–291.